jenny, Author at Society for Pediatric Pain Medicine

Electroencephalographic Characteristics of Children and Adolescents with Chronic Musculoskeletal Pain

A recently published study suggests that EEG can characterize subtle differences in heat and cold pain sensitivity in patients with chronic musculoskeletal pain. Utilizing EEG and evoked pain can better detect underlying pain mechanisms and changes in pain sensitivity.

Read the full study here: https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/36601627/

Question of the Month – February 2023

A 17-year-old male patient presents to the OR for emergent right ankle open reduction internal fixation for fracture of the right ankle obtained when playing basketball. The patient has a past medical history of well-controlled asthma, eczema, and seasonal allergies. He also has a history of opioid use disorder that was diagnosed after he was noted to have aberrant behavior in his classroom and his mother found her post-operative oxycodone pill bottle was empty. Six months ago, he was placed on medication for opioid use disorder (MOUD) that included buprenorphine 4 mg sublingual twice per day. Which of the following is NOT a correct statement regarding buprenorphine?

A. Buprenorphine should not be routinely discontinued or tapered in the perioperative setting.

B. Buprenorphine is extensively metabolized by the liver via CYP3A4 with first pass metabolism and has low oral bioavailability.

C. In order for a clinician to prescribe buprenorphine they need to first obtain a DATA-waiver (X-waiver).

D. Buprenorphine is 25-40 times more potent than morphine.

Correct! Wrong!

Question of the Month - February 2023

SPPM is NOW on YouTube!

SPPM has launched an official YouTube channel where our latest videos including our popular Visual Pearl series are available for easy access and education.

Subscribe to our channel here: www.youtube.com/@PedsPainMed

Question of the Month – January 2023

A 17-year-old girl presents to your chronic pain clinic with neuropathic pain of her right leg secondary to osteosarcoma of the right femur. She has severe persistent neuropathic pain despite treatment with pregabalin, duloxetine, physiotherapy, and psychological treatments. The teen and her parents are interested in exploring cannabinoids for treatment of her pain and want to discuss this further with you. Which one of the following statements is incorrect?

A. Recent systematic review on cannabinoids as medical treatment in children and adolescents showed insufficient evidence for its use in chronic pain conditions such as spasticity and neuropathic pain.

B. There is evidence from recreational cannabis users suggesting the chronic use of cannabis may have adverse effects on the developing brain.

C. Nabilone is an orally administered synthetic cannabinoid and analogue of cannabidiol (CBD).

D. In a small cohort study on the use of nabilone in children with severe non-cancer pain, the most common reported side effects were sedation and cognitive slowing.

Correct! Wrong!

Question of the Month - January 2023

Member Menu

Electroencephalographic Characteristics of Children and Adolescents with Chronic Musculoskeletal Pain

Question of the Month – February 2023

SPPM is NOW on YouTube!

Question of the Month – January 2023

Improving Preclinical Development of Novel Interventions to Treat Pain: Insanity is Doing the Same Thing Over and Over and Expecting Different Results

Upcoming Meeting Information